PPRC1 Activators refer to a class of chemical compounds that are known to modulate the activity or expression of PPRC1 (PPARG-Related Coactivator 1), a coactivator protein with essential roles in regulating gene transcription and influencing various cellular processes. PPRC1 itself serves as a crucial link in cellular signaling cascades, particularly within the context of metabolic regulation and transcriptional control. PPRC1 activity is typically regulated through protein-protein interactions and post-translational modifications, rather than direct small molecule activation. It functions as a coactivator by interacting with transcription factors like PPARγ to enhance their transcriptional activity.
PPARγ (Peroxisome Proliferator-Activated Receptor gamma) agonists are a class of small molecules that specifically activate PPARγ, a nuclear receptor involved in the regulation of various metabolic processes, including adipogenesis, insulin sensitivity, and lipid metabolism. While the primary role of PPARγ agonists is to directly activate PPARγ, their downstream effects can indirectly influence the activity and expression of PPRC1 (PPARG-Related Coactivator 1), a coactivator that enhances PPARγ's transcriptional activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a widely known Thiazolidinedione and a potent PPARγ agonist studied in the research of type 2 diabetes. Activation of PPARγ by rosiglitazone can lead to increased expression of PPRC1, as PPRC1 is a coactivator involved in PPARγ-mediated gene regulation. | ||||||
Pioglitazone hydrochloride | 112529-15-4 | sc-204848 sc-204848A | 100 mg 500 mg | $63.00 $213.00 | 19 | |
Pioglitazone is another Thiazolidinedione agent in research used to treat type 2 diabetes. Like rosiglitazone, it activates PPARγ and can indirectly impact PPRC1 expression and activity. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Troglitazone is an older Thiazolidinedione that was used for diabetes treatment but is less commonly prescribed today due to safety concerns. It is also a PPARγ agonist that can affect PPRC1 expression. | ||||||